Sabio Holdings is still a buy, this analyst says

Beacon Securities analyst Gabriel Leung said in a Nov. 25 update that Sabio Holdings (Sabio Holdings Stock Quote, Chart, News, Analysts, Financials TSXV:SBIO) delivered a weaker-than-expected third quarter but continues to show signs that revenue momentum could rebuild in 2026.

Leung maintained his “Buy” rating and C$0.80 target.

Sabio provides mobile and connected-TV advertising solutions, including targeting, reach, and analytics tools.

Leung said Q3 results “looked challenged,” with revenue of US$8.2-million and negative EBITDA of US$2.2-million, versus his forecasts of US$11.7-million and negative US$1-million.

He noted that Sabio’s switch to reporting programmatic transactions on a net basis had the effect of lowering revenue and cost of goods sold equally, keeping gross profit intact. On a gross basis, Q3 revenue would have been US$9.3-million.

Mobile ad revenue fell 47% year over year to US$1.8-million, while connected-TV revenue dropped 49% to US$6.2-million. But Leung said the comparison was distorted by a surge in political and advocacy spending last year; excluding that category, CTV gross revenue would have been up 2%.

He attributed the overall declines to “tough y/y comparables” and early budget shifts in several verticals ahead of U.S. tariff changes. Still, he highlighted several positives: programmatic revenue of US$1.9-million versus none a year ago, and a 240% increase in international revenue, which accounted for 19% of gross revenue.

The company expects Q4 to benefit from seasonal uplift, and Leung said Sabio indicated its Q1 2026 pipeline is up roughly 60% year over year, with next year’s U.S. midterm election cycle likely to provide another meaningful tailwind. Gross margin was 58.7%, down from 63% last year. Free cash flow was roughly US$1-million, and Sabio ended the quarter with US$2-million in cash against US$6.9-million in debt. After quarter-end, it raised C$1.28-million through a share issue.

Leung said he expects a “strong rebound” beginning in Q4 and continuing into 2026, driven by political spending, expanding programmatic revenue, and continued growth in international markets. His valuation is based on 10× CY26e EV/EBITDA.

He forecasts Sabio will post US$40.4-million in revenue and negative US$5.2-million in Adjusted EBITDA for fiscal 2025, improving to US$59.9-million in revenue and US$3.9-million in Adjusted EBITDA in fiscal 2026.

-30-

Tagged with: sbio
Nick Waddell

Cantech Letter founder and editor Nick Waddell has lived in five Canadian provinces and is proud of his country's often overlooked contributions to the world of science and technology. Waddell takes a regular shift on the Canadian media circuit, making appearances on CTV, CBC and BNN, and contributing to publications such as Canadian Business and Business Insider.

Recent Posts

This cannabis stock is a “Top Pick” for 2026, analyst says

Haywood Securities analyst Neal Gilmer maintained his “Buy” rating and $19.00 price target on Green Thumb Industries (Green Thumb Industries… [Read More]

15 hours ago

Can AI glasses make Warby Parker’s stock sexy?

Roth Capital Markets analyst Matt Koranda raised his price target on Warby Parker (Warby Parker Stock Quote, Chart, News, Analysts,… [Read More]

16 hours ago

This analyst just chopped his price target on Cargojet

Beacon Securities analyst Donangelo Volpe lowered his price target on Cargojet (Cargojet Stock Quote, Chart, News, Analysts, Financials TSX:CJT) following… [Read More]

16 hours ago

This analyst loves Spectral Medical

Research Capital analyst Andre Uddin maintained his “Speculative Buy” rating and C$3.50 price target on Spectral Medical (Spectral Medical Stock… [Read More]

17 hours ago

This analyst just raised his price target on Volatus Aerospace

Ventum Capital Markets analyst Rob Goff maintained his “Buy” rating on Volatus Aerospace (Volatus Aerospace Stock Quote, Chart, News, Analysts,… [Read More]

17 hours ago

Is Trulieve Cannabis a buy right now?

Haywood Securities analyst Neal Gilmer reiterated his “Buy” rating and C$19.00 price target on Trulieve Cannabis (Trulieve Cannabis Stock Quote,… [Read More]

17 hours ago